From: Clinical significance and biological roles of lncRNA CTBP1-AS in polycystic ovary syndrome
Clinical indicators | PCOS (N = 85) | Control(N = 40) | t / Z | p value |
---|---|---|---|---|
Age(years) | 26(24,29) | 28(24, 31) | -1.397 | 0.163 |
Duration of infertility (years) | 2(1, 4) | 2(1, 4) | -0.51 | 0.61 |
Menstrual cycles(days) | 68(60, 90) | 31(30, 40) | -7.907 | < 0.001* |
Antral follicle count | 31(28, 40) | 18(15, 20) | -8.358 | < 0.001* |
Basic sex hormone | ||||
FSH (IU/L) | 5.78 ± 1.84 | 5.81 ± 1.78 | -0.095 | 0.925 |
LH (IU/L) | 8.67(5.53, 12.60) | 4.16(3.64, 5.39) | -5.547 | < 0.001* |
E2 (pg/mL) | 56.0(45.0, 68.5) | 47.0(38.0, 59.7) | -2.844 | 0.004* |
P (ng/mL) | 0.46(0.30, 0.70) | 0.49(0.22, 0.60) | -0.506 | 0.613 |
T (ug/L) | 0.76 ± 0.27 | 0.47 ± 0.19 | 6.253 | < 0.001* |
PRL (ug/L) | 12.58 ± 5.74 | 10.80 ± 4.84 | 1.7 | 0.092 |
AMH (ng/mL) | 7.55(5.00,10.62) | 4.48(2.37, 6.48) | -4.701 | < 0.001* |
FPG (mmol/L) | 4.87(4.60, 5.23) | 4.75(4.52, 5.15) | -1.5 | 0.134 |
FINS (pmol/L) | 75.0(58.1, 89.1) | 52.0(40.5, 68.5) | -4.01 | < 0.001* |
HOMAIR | 2.44(1.77, 2.91) | 1.57(1.26, 2.08) | -4.319 | < 0.001* |
BMI (kg/m2) | 22.7(20.1, 24.9) | 21.3(19.1, 24.9) | -1.527 | 0.127 |